Inmed Pharmaceuticals Inc (INM)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Inmed Pharmaceuticals Inc Stock (INM) Company Profile

Inmed Pharmaceuticals Inc

Healthcare (1165)

(604) 669-7207

1445-885 WEST GEORGIA ST., VANCOUVER

Nächster Verdiensttermin

Neueste SEC-Einreichungen

INM's Discussions on Twitter

Vergleichen Sie INM mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
INM Inmed Pharmaceuticals Inc	2.06	2.51M	4.96M	-6.82M	-6.64M	-65.40
ZTS Zoetis Inc	163.31	72.50B	9.26B	2.49B	2.30B	5.47
TAK Takeda Pharmaceutical Co Adr	14.95	47.08B	30.25B	1.37B	5.08B	0.4257
HLN Haleon Plc Adr	10.13	45.99B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	15.28	17.38B	16.54B	-1.64B	749.00M	-1.45
ITCI Intra Cellular Therapies Inc	131.87	14.05B	612.78M	-86.37M	-62.91M	-0.87

Inmed Pharmaceuticals Inc Aktie (INM) Neueste Nachrichten

Finanzdaten der Inmed Pharmaceuticals Inc-Aktie (INM)

Inmed Pharmaceuticals Inc (INM)

Inmed Pharmaceuticals Inc Stock (INM) Company Profile

Vergleichen Sie INM mit anderen Aktien

Inmed Pharmaceuticals Inc Aktie (INM) Neueste Nachrichten

InMed Pharmaceuticals Stock Hits 52-Week Low at $2.34 - Investing.com India

InMed Pharmaceuticals Stock Hits 52-Week Low at $2.34 By Investing.com - Investing.com Australia

InMed Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

InMed Pharmaceuticals Struggles with Losses Amid Revenue Decline - MSN

InMed Pharmaceuticals Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update - Defense World

InMed Pharmaceuticals Board Reshuffle After Director Resignation - TipRanks

InMed Pharmaceuticals Reports Q2 2025 Financial Results - TipRanks

InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update - Yahoo Finance

InMed Pharmaceuticals Inc. (INM) reports earnings - Quartz

InMed Pharmaceuticals Inc. SEC 10-Q Report - TradingView

InMed's Mixed Q2 Results Reveal Hidden Gem: Subsidiary Turns 189% Profit as Pipeline Advances - Stock Titan

InMed Advances INM-089 for Dry AMD Treatment with New Intravitreal Formulation - TipRanks

Inmed selects IVT formulation of INM-089 for dry AMD - BioWorld Online

InMed advances AMD treatment with promising IVT drug formulation - MSN

Revolutionary Eye Drug INM-089 Achieves 10X Therapeutic Levels in Macular Degeneration Treatment - StockTitan

Inmed Pharmaceuticals Inc (INM-Q) QuotePress Release - The Globe and Mail

InMed Pharmaceuticals (NASDAQ: INM) Secures International Patent for Novel Compounds - Defense World

InMed Pharmaceuticals Secures Key Patent for Cannabinoid Analogs - TipRanks

InMed Pharmaceuticals secures international patent - Investing.com India

InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds - Newsfile

InMed Secures Breakthrough 20-Year Patent in Mexico for Novel Cannabinoid Compounds - StockTitan

Nano-Cap InMed Ignites Retail Frenzy As Stock Soars After Alzheimer's Drug Trial Shows Promise - Asianet Newsable

InMed Pharmaceuticals (NASDAQ: INM) Announces Positive Results from INM-901 Alzheimer’s Disease Study - Defense World

InMed Hails Alzheimer's Study, Stocks Shoot Higher - Baystreet.ca

InMed announces ‘positive’ results from in vivo preclinical Alzheimer’s study - TipRanks

InMed’s INM-901 Shows Promising Results in Preclinical Alzheimer’s Study - TipRanks

InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study - Newsfile

SABBY MANAGEMENT, LLC Acquires Shares in InMed Pharmaceuticals I - GuruFocus

InMed Pharmaceuticals Inc. Holds 2024 Annual General Meeting – Elects Directors and Appoints Auditor - Defense World

InMed Pharmaceuticals Director Faces Resignation After Shareholder Vote at Annual Meeting - StockTitan

InMed Announces Results of 2024 Annual General Meeting - Newsfile

InMed Pharmaceuticals Inc. announced that it expects to receive CAD 10 million in funding - Marketscreener.com

InMed Enters Into Standby Equity Purchase Agreement - Newsfile

Head-To-Head Review: InMed Pharmaceuticals (NASDAQ:INM) & Rocket Pharmaceuticals (NASDAQ:RCKT) - Defense World

InMed Pharmaceuticals Secures $10M Equity Purchase Agreement in Strategic Financing Move - Stock Titan

InMed Pharmaceuticals (TSE:IN) Trading Down 1.6% – Time to Sell? - Defense World

InMed Pharmaceuticals (FRA:MWG) Altman Z-Score : -14.86 (As of Dec. 05, 2024) - GuruFocus.com

InMed Pharmaceuticals (FRA:MWG) Altman Z-Score : -14.90 (As of Dec. 03, 2024) - GuruFocus.com

InMed Pharmaceuticals (FRA:MWG) Inventories, Finished Goods : €0.84 Mil (As of Sep. 2024) - GuruFocus.com

InMed Pharmaceuticals (FRA:MWG) Shares Outstanding (EOP) : 0.67 Mil (As of Sep. 2024) - GuruFocus.com

INM (InMed Pharmaceuticals) Total Liabilities : $2.07 Mil (As of Sep. 2024) - GuruFocus.com

INM (InMed Pharmaceuticals) Debt-to-Equity : 0.13 (As of Sep. 2024) - GuruFocus.com

INM (InMed Pharmaceuticals) Dividend Yield % : 0.00% (As of Nov. 26, 2024) - GuruFocus.com

INM (InMed Pharmaceuticals) Dividend Payout Ratio : 0.00 (As of Sep. 2024) - GuruFocus.com

INM (InMed Pharmaceuticals) EBITDA : $-6.66 Mil (TTM As of Sep. 2024) - GuruFocus.com

INM (InMed Pharmaceuticals) 3-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com

INM (InMed Pharmaceuticals) Cash, Cash Equivalents, Marketa - GuruFocus.com

INM (InMed Pharmaceuticals) Growth Rank : 0 (As of Nov. 26, 2024) - GuruFocus.com

INM (InMed Pharmaceuticals) Machinery, Furniture, Equipment : $0.04 Mil (As of Sep. 2024) - GuruFocus.com

INM (InMed Pharmaceuticals) 3-Year EPS without NRI Growth R - GuruFocus.com

INM (InMed Pharmaceuticals) Total Inventories : $1.22 Mil (As of Sep. 2024) - GuruFocus.com

Finanzdaten der Inmed Pharmaceuticals Inc-Aktie (INM)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie INM